Renagel is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, Llc. The primary component is Sevelamer Hydrochloride.
| Product ID | 67544-656_7bba784e-b2dd-4662-a66d-09246be23c7c |
| NDC | 67544-656 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Renagel |
| Generic Name | Renagel |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2008-06-06 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021179 |
| Labeler Name | Aphena Pharma Solutions - Tennessee, LLC |
| Substance Name | SEVELAMER HYDROCHLORIDE |
| Active Ingredient Strength | 800 mg/1 |
| Pharm Classes | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2008-06-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021179 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2008-06-06 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| SEVELAMER HYDROCHLORIDE | 800 mg/1 |
| SPL SET ID: | b27c1744-1d96-4f9f-b621-e24a795b7534 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 17856-0021 | Renagel | Renagel |
| 53808-0777 | Renagel | Renagel |
| 58468-0020 | Renagel | Renagel |
| 58468-0021 | Renagel | sevelamer hydrochloride |
| 67544-656 | Renagel | Renagel |
| 68151-4295 | RENAGEL | Renagel |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RENAGEL 74590044 1978935 Live/Registered |
GENZYME CORPORATION 1994-10-24 |